Nicholas A. Medland

Nicholas A. Medland

Auto-generated profile, based on publicly available information

Nicholas A. Medland

Kirby Institute, University of New South Wales, Sydney, Australia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2009 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ARAlison J. Rodger
Alison J. Rodger
ZFZoe Fox
Zoe Fox
JLJens Lundgren
Jens Lundgren
LKLewis H. Kuller
Lewis H. Kuller
CBChristoph Boesecke
Christoph Boesecke
TGthe INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
BackgroundActivation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their ass

1 January 2015 in Journal of the International AIDS Society
Verified
Journal Article
Open access
PDF file
NMNicholas A Medland
Nicholas A Medland
JMJames H McMahon
James H McMahon
ECEric P.F. Chow
Eric P.F. Chow
JEJulian H Elliott
Julian H Elliott
JHJennifer F. Hoy
Jennifer F. Hoy
CFChristopher K Fairley
Christopher K Fairley
Introduction: The cascade of HIV diagnosis, care and treatment (HIV care cascade) is increasingly used to direct and evaluate interventions to increase population antiretroviral therapy (ART) coverage, a key component of treatment as prevention. The ability to compare cascades over time, sub‐population, jurisdiction or country is important. However, differences in data sources and methodology used to construct the HIV care cascade might limit its comparability and ultimately its utility. Our aim was to review systematically the different methods used to estimate and report the HIV care cascade and their comparability.Methods: A search of published and unpublished literature through March 2015 was conducted. Cascades that reported the continuum of care from diagnosis to virological suppression in a demographically definable population were included. Data sources and methods of measurement or estimation were extracted. We defined the most comparable cascade elements as those that directly measured diagnosis or care from a population‐based data set.Results and discussions: Thirteen reports were included after screening 1631 records. The undiagnosed HIV‐infected population was reported in seven cascades, each of which used different data sets and methods and could not be considered to be comparable. All 13 used mandatory HIV diagnosis notification systems to measure the diagnosed population. Population‐based data sets, derived from clinical data or mandatory reporting of CD4 cell counts and viral load tests from all individuals, were used in 6 of 12 cascades reporting linkage, 6 of 13 reporting retention, 3 of 11 reporting ART and 6 of 13 cascades reporting virological suppression. Cascades with access to population‐based data sets were able to directly measure cascade elements and are therefore comparable over time, place and sub‐population. Other data sources and methods are less comparable.Conclusions: To ensure comparability, countries wishing to accurately measure the cascade should utilize complete population‐based data sets from clinical data from elements of a centralized healthcare setting, where available, or mandatory CD4 cell count and viral load test result reporting. Additionally, virological suppression should be presented both as percentage of diagnosed and percentage of estimated total HIV‐infected population, until methods to calculate the latter have been standardized.

11 November 2022 in Sexual Health
Verified
Journal Article
Open access
PDF file
JOJason J. Ong
Jason J. Ong
CBChristopher Bourne
Christopher Bourne
JDJudith Ann Dean
Judith Ann Dean
NRNathan Ryder
Nathan Ryder
VCVincent Cornelisse
Vincent Cornelisse
NMNicholas A Medland
Nicholas A Medland
The ‘Australian Sexually Transmitted Infection (STI) Management Guidelines For Use In Primary Care’ (www.sti.guidelines.org.au) provide evidence-based, up-to-date guidance targeted at use in primary care settings. A major review of the guidelines was undertaken in 2020–22. All content was reviewed and updated by a multi-disciplinary group of clinical and non-clinical experts, and assessed for appropriateness of recommendations for key affected populations and organisational and jurisdictional suitability. The guidelines are divided into six main sections: (1) standard asymptomatic check-up; (2) sexual history; (3) contact tracing; (4) STIs and infections associated with sex; (5) STI syndromes; and (6) populations and situations. This paper highlights important aspects of the guidelines and provides the rationale for significant changes made during this major review process.

1 December 2003 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
NLN. A. Ba/Sc(Hons) Lister
N. A. Ba/Sc(Hons) Lister
ASA. Bsc(Hons) Smith
A. Bsc(Hons) Smith
STS. Tabrizi
S. Tabrizi
PHP. RN Hayes
P. RN Hayes
NMN. A. Mbbs Medland
N. A. Mbbs Medland
CFC. K. PhD Fairley
C. K. PhD Fairley
Background and Objectives In response to increases in sexually transmissible infections (STI) and HIV infection rates among men who have sex with men (MSM), the current study aimed to investigate the feasibility of a screening program at male-only saunas in Melbourne, Australia. Goal The goal was to determine (1) the participation rate, and the proportion whom obtain test results; (2) the prevalence of gonorrhea and chlamydia; and (3) to evaluate risk factors for STI acquisition. Study Design We used a cross-sectional design. Pharyngeal, rectal, and urethral specimens were collected from participants, and tested for Chlamydia trachomatis and Neisseria gonorrhoeae by polymerase chain reaction (PCR). Results There was a participation rate of 24% (n = 521), and 70% obtained their test results. The infection rate in those who failed to collect their results was no different than those seeking theirs. The proportion of participants with PCR-detected gonorrhea and/or chlamydia infection was high, 10.7%. The presence of infection was associated with seeking sexual health care in the last year. Conclusion The high prevalence rate of gonorrhea and chlamydia supports the concept of a screening program in Melbourne male-only saunas. The low participation rate has highlighted the need to consider alternative methods for making contact with men in the saunas or offering incentives to participate in future screening programs. Although anonymous participation encouraged participation for some men, future programs should attempt to obtain contact details for follow up of positive test results.

13 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ÁBÁlvaro H. Borges
Álvaro H. Borges
JOJemma L. O’cOnnor
Jemma L. O’cOnnor
APAndrew N. Phillips
Andrew N. Phillips
JBJason V. Baker
Jason V. Baker
MVMichael J. Vjecha
Michael J. Vjecha
FCfor the INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee
for the INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee
Higher plasma D-dimer levels are strong predictors of mortality in HIV+ individuals. The factors associated with D-dimer levels during HIV infection, however, remain poorly understood. In this cross-sectional study, participants in three randomized controlled trials with measured D-dimer levels were included (N = 9,848). Factors associated with D-dimer were identified by linear regression. Covariates investigated were: age, gender, race, body mass index, nadir and baseline CD4+ count, plasma HIV RNA levels, markers of inflammation (C-reactive protein [CRP], interleukin-6 [IL-6]), antiretroviral therapy (ART) use, ART regimens, co-morbidities (hepatitis B/C, diabetes mellitus, prior cardiovascular disease), smoking, renal function (estimated glomerular filtration rate [eGFR] and cystatin C) and cholesterol. Women from all age groups had higher D-dimer levels than men, though a steeper increase of D-dimer with age occurred in men. Hepatitis B/C co-infection was the only co-morbidity associated with higher D-dimer levels. In this subgroup, the degree of hepatic fibrosis, as demonstrated by higher hyaluronic acid levels, but not viral load of hepatitis viruses, was positively correlated with D-dimer. Other factors independently associated with higher D-dimer levels were black race, higher plasma HIV RNA levels, being off ART at baseline, and increased levels of CRP, IL-6 and cystatin C. In contrast, higher baseline CD4+ counts and higher high-density lipoprotein cholesterol were negatively correlated with D-dimer levels. D-dimer levels increase with age in HIV+ men, but are already elevated in women at an early age due to reasons other than a higher burden of concomitant diseases. In hepatitis B/C co-infected individuals, hepatic fibrosis, but not hepatitis viral load, was associated with higher D-dimer levels.

20 August 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NMNicholas A. Medland
Nicholas A. Medland
ECEric P.F. Chow
Eric P.F. Chow
TRTimothy H. R. Read
Timothy H. R. Read
JOJason J. Ong
Jason J. Ong
MCMarcus Chen
Marcus Chen
CFChristopher K. Fairley
Christopher K. Fairley
We examined differences in incident HIV infection between newly-arrived Asian-born and other men who have sex with men (MSM) after the introduction of universal HIV treatment guidelines in 2015 and pre-exposure prophylaxis in 2016. Clinical, demographic, laboratory and behavioural data on MSM presenting for HIV testing at the Melbourne Sexual Health Centre from July 2013 to June 2017 were extracted. We compared the proportion of newly-arrived (four years or less in Australia), Asian-born and other MSM tested each year who were diagnosed with incident HIV infection (negative test within one year or diagnosis with indeterminate or negative Western Blot). We analysed 35,743 testing episodes in 12,180 MSM, including 2781 testing episodes in 1047 newly-arrived Asian-born MSM. The proportion of other MSM tested each year who were diagnosed with incident HIV infection fell from 0.83% in 2014 to 0.38% in 2017 (p = .001), but did not fall in newly-arrived Asian-born MSM (from 1.18% in 2014 to 1.56% in 2017, p = .76). In the multivariate logistic regression, in 2016/2017 but not in 2014/2015, being newly-arrived Asian-born was associated with an increased odds of diagnosis of incident HIV infection (aOR 3.29, 95%CI 1.82–5.94, p < .001). The epidemiology of HIV in Melbourne Australia has changed dramatically. While there has been an overall reduction amongst MSM, the incidence of HIV in newly-arrived Asian-born MSM remains high. Failing to address these new inequalities leaves individuals at risk and may offset the population benefit of biomedical HIV prevention.